RecruitingNCT05824403
PAncreatic Disease Cohort of TOuLouse
Sponsor
University Hospital, Toulouse
Enrollment
300 participants
Start Date
Nov 28, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Patients with inflammatory or cystic exocrine pancreatic pathology
- Patient able to read and understand the information leaflet
- Patients who have agreed to participate in the study and have signed the free and informed consent
- Patients affiliated to a social security system (including AME)
Exclusion Criteria4
- Patient with pancreatic cancer pathology
- Patients with active cancer, whatever the origin
- Pregnant or breastfeeding patients
- Patients under legal protection, guardianship or trusteeship
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05824403
Related Trials
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT0333470813 locations
UCSF PANC Cyst Registry
NCT042916511 location
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study
NCT070303483 locations
Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations
NCT060410091 location
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
NCT044936329 locations